Deucravacitinib
CAS 1609392-27-9
In Stock
Deucravacitinib
Cat. No. STUB-API-DEUCRAVACITINIBCAS 1609392-27-9In Stock
Technical Data
Cat. No.STUB-API-DEUCRAVACITINIB
CAS1609392-27-9
Mol. FormulaC20H22N8O3
Mol. Weight425.4673 g/mol
IUPAC6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide
SMILES[2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4
InChIInChI=1S/C20H22N8O3/c1-21-20(30)16-14(9-15(25-26-16)24-19(29)11-7-8-11)23-13-6-4-5-12(17(13)31-3)18-22-10-28(2)27-18/h4-6,9-11H,7-8H2,1-3H3,(H,21,30)(H2,23,24,25,29)/i1D3
InChI KeyBZZKEPGENYLQSC-FIBGUPNXSA-N
Purity—
Description
Overview
Deucravacitinib is a targeted treatment for patients with moderate-to-severe plaque psoriasis who qualify for systemic therapy or phototherapy
Anant Labs manufacture and furnish high quality Deucravacitinib impurities for global markets. Our Deucravacitinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
Deucravacitinib1609392-27-9BMS-986165SotyktuN0A21N6RAURefChem:58358Tyk2-IN-4BMS9861656-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamideDeucravacitinib [USAN]
